Selenoprotein thioredoxin reductase mediated menadione reduction: catalytic properties & inhibition effects.

Nan Zhang; Shibo Sun; Yue Zhang; Yijia Yang; Yici Zhang; Jihong Chen; Weiping XU; Qiang MA; Jianqiang XU

Return

Selenoprotein thioredoxin reductase mediated menadione reduction: catalytic properties & inhibition effects.

Author: Nan ZHANG ¹ ; Shibo SUN ¹ ; Yue ZHANG ¹ ; Yijia YANG ¹ ; Yici ZHANG ¹ ; Jihong CHEN ¹ ; Weiping XU ² ; Qiang MA ³ ; Jianqiang XU ¹
Author Information

1. School of Life and Pharmaceutical Sciences (LPS) and Panjin Institute of Industrial Technology, Dalian University of Technology, Panjin 124221, Liaoning, China.
2. School of Ocean Science and Technology (OST), Dalian University of Technology, Panjin 124221, Liaoning, China.
3. Chinese Academy of Inspection and Quarantine, Beijing 100176, China.
Publication Type:Journal Article
Keywords: inhibition; liquid chromatography-mass spectrometry (LC-MS); menadione; reactive oxygen species (ROS); residue modification; thioredoxin reductase
MeSH: Catalysis; Drug Development; Oxidation-Reduction; Thioredoxin Reductase 1/metabolism*; Vitamin K 3/metabolism*
From: Chinese Journal of Biotechnology 2020;36(10):2139-2150
CountryChina
Language:Chinese
Abstract: Thioredoxin reductase (TrxR) is one class of the most important antioxidant selenoproteins and is involved in regulating tumor genesis and progression. It has been reported that naphthoquinones can target and inhibit TrxR1 activity therefore produce reactive oxygen species (ROS) mediated by TrxR1, resulting into cellular redox imbalance and making the naphthoquinone compounds to become potential antitumor chemotherapy drugs. The purpose of this work is to explore the interaction between TrxR1 and menadione using biochemical and mass-spectrometric (MS) analyses, to further reveal the detailed mechanisms of TrxR1-mediated naphthoquinone reduction and inhibition of TrxR1 by naphthoquinone compounds. Using the site-directed mutagenesis and recombinantly expressed TrxR1 variants, we measured the steady-state kinetic parameters of menadione reduction mediated by TrxR1 and its variants, performed the inhibition analysis of menadione on TrxR1 activity, and eventually identified the interaction between menadione and TrxR1 through MS analysis. We found that Sec-to-Cys mutation at residue of 498 significantly enhanced the efficiency of TrxR1-mediated menadione reduction, though the Sec⁴⁹⁸ is capable to catalyze the menadione reduction, indicating that TrxR1-mediated menadione reduction is dominantly in a Se-independent manner. Mutation experiments showed that Cys⁴⁹⁸ is mainly responsible for menadione catalysis in comparison to Cys⁴⁹⁷, while the N-terminal Cys⁶⁴ is slightly stronger than Cys⁵⁹ regarding the menadione reduction. LC-MS results detected that TrxR1 was arylated with one molecule of menadione, suggesting that menadione irreversibly modified the hyper-reactive Sec residue at the C-terminus of selenoprotein TrxR1. This study revealed that TrxR1 catalyzes the reduction of menadione in a Se-independent manner meanwhile its activity is irreversibly inhibited by menadione. Hereby it will be useful for the research and development of naphthoquinone anticancer drugs targeting TrxR1.